Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

Completed

NCT00299767

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +18 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Completed

NCT00262860

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States

James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States

Completed

NCT00896662

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +30 more
Locations: Not specified

Completed

NCT01804335

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

Completed

NCT01213095

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Sung Yong Oh Busan, South Korea

Completed

NCT00765245

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

Completed

NCT02221492

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Investigational Site Number 392005 Chiba, Japan

Investigational Site Number 392011 Fukuoka, Japan

Investigational Site Number 392014 Fukuyama-Shi, Japan

Investigational Site Number 392010 Hamamatsu, Japan

Lymphoma

Lymphoma trial results